How small- and mid-cap quoted companies make a substantial contribution to markets, employment and tax revenues.
03 May 2019
The Monthly May 2019
Time Finance plc (TIME:LON), 48.2 | AJ Bell Plc (AJB:LON), 544 | Arbuthnot Banking Group PLC (ARBB:LON), 902 | City of London Investment Group PLC (CLIG:LON), 389 | DP Poland PLC (DPP:LON), 8.0 | Gateley (Holdings) Plc (GTLY:LON), 114 | Genedrive Plc (GDR:LON), 0.5 | Haydale Graphene Industries Plc (HAYD:LON), 0.6 | Koovs (KOOV:LON), 0 | Lightwaverf (LWRF:LON), 0 | Murgitroyd Group (MUR:LON), 0 | Oxford BioMedica plc (OXB:LON), 610 | Palace Capital plc (PCA:LON), 216 | Primary Health Properties PLC (PHP:LON), 94.6 | R.E.A. Holdings plc (RE:LON), 110 | Shield Therapeutics Plc (STX:LON), 7.3 | Tissue Regenix Group plc (TRX:LON), 7.2 | Titon Holdings Plc (TON:LON), 90.0 | Volta Finance Limited (VTA:LON), 675 | Warpaint London PLC (W7L:LON), 220
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
The Monthly May 2019
Time Finance plc (TIME:LON), 48.2 | AJ Bell Plc (AJB:LON), 544 | Arbuthnot Banking Group PLC (ARBB:LON), 902 | City of London Investment Group PLC (CLIG:LON), 389 | DP Poland PLC (DPP:LON), 8.0 | Gateley (Holdings) Plc (GTLY:LON), 114 | Genedrive Plc (GDR:LON), 0.5 | Haydale Graphene Industries Plc (HAYD:LON), 0.6 | Koovs (KOOV:LON), 0 | Lightwaverf (LWRF:LON), 0 | Murgitroyd Group (MUR:LON), 0 | Oxford BioMedica plc (OXB:LON), 610 | Palace Capital plc (PCA:LON), 216 | Primary Health Properties PLC (PHP:LON), 94.6 | R.E.A. Holdings plc (RE:LON), 110 | Shield Therapeutics Plc (STX:LON), 7.3 | Tissue Regenix Group plc (TRX:LON), 7.2 | Titon Holdings Plc (TON:LON), 90.0 | Volta Finance Limited (VTA:LON), 675 | Warpaint London PLC (W7L:LON), 220
- Published:
03 May 2019 -
Author:
Hardman & Co Research Team -
Pages:
40 -
How small- and mid-cap quoted companies make a substantial contribution to markets, employment and tax revenues.